I reckon this was the only reason for the massive MC appreciation - the prospect of a TO or licensing agreement from Imugene after good pre-clinical results.
The risk that this would not eventuate increased when Imugene licensed Azer-Cel.
I reckon this was the only reason for the massive MC...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $136.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $133.5K | 1.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11996 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 367267 | 9 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.8¢ |
Change
0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 12.5¢ | 13.0¢ | 12.5¢ | 582454 | ||
| Last updated 14.53pm 03/05/2024 ? | |||||
| ALA (ASX) Chart |